British Dragon
British Dragon
BPC 157 5 mg
Product Information Compound Details
Active Substance BPC-157 Body Protection Compound · Synthetic Pentadecapeptide
5 mgStrength 5 mg/vial
Package 1 Vial
Form Lyophilized Powder
Vial Size 2 mL Vial
Drug Class Research Peptide
Manufacturer British Dragon
Shipping :
International
U.S. Domestic
Out of stock
- Overview
- Profile
- Usage
- Safety
- Shipping
- Storage
- FAQ
- Reviews
Product Overview
BPC 157 5 mg by British Dragon
BPC 157 5 mg is a lyophilized pentadecapeptide research product manufactured by British Dragon and supplied as a 5 mg/vial powder in a 2 mL vial.
Pentadecapeptide Injectable
BPC 157 5 mg contains the synthetic pentadecapeptide commonly known as Body Protection Compound 157, or BPC-157. This fifteen-amino-acid sequence is derived from a region of human gastric juice protein and has been studied extensively in preclinical models for its effects on tissue repair and recovery processes.
In preclinical research settings, BPC-157 has been observed to influence pathways associated with angiogenesis, fibroblast activity, and cellular protection across various tissue types. These properties have generated interest in both academic research and non-medical bodybuilding communities, where it is commonly referenced for tendon, ligament, and muscle recovery support.
It is important to note that BPC-157 is not an FDA-approved human drug, and its non-medical use for performance or recovery purposes falls outside approved indications. Human clinical evidence remains limited, though investigational studies are ongoing.
Key Benefits of BPC 157 5 mg
- Lyophilized powder format for reconstitution flexibility
- Pentadecapeptide sequence associated with tissue repair pathways
- Commonly referenced in tendon and ligament recovery contexts
- 5 mg per vial for research and non-medical protocols
- Manufactured by British Dragon
Formulation
Lyophilized Powder
BPC 157 5 mg is supplied as a lyophilized (freeze-dried) powder in a 2 mL vial. Reconstitution with an appropriate solvent is required before use in research or non-medical contexts.
Product Profile
Pentadecapeptide Profile
BPC-157 is a stable gastric pentadecapeptide with a molecular weight of approximately 1,419 Da. Its amino acid sequence is GEPPPGKPADDAGLV.
Research Peptide
BPC-157 belongs to a class of synthetic peptides investigated for cytoprotective and tissue-repair properties. Unlike classic anabolic steroids, it does not act through androgen receptor pathways; its proposed mechanisms involve modulation of angiogenesis, nitric oxide signaling, and growth factor expression.
The peptide is stable in human gastric juice and has demonstrated high safety margins in animal studies, with no lethal dose established in toxicology research. However, human pharmacokinetic data is essentially absent, and dosing remains speculative.
In non-medical bodybuilding contexts, BPC-157 is commonly referenced for localized soft-tissue recovery, particularly for tendon, ligament, and muscle injuries, though such use lacks rigorous clinical validation.
Defining Characteristic
Pentadecapeptide Sequence
BPC-157 is a synthetic 15-amino-acid fragment derived from a protective protein found in human gastric juice. This short sequence is the basis for its classification as a pentadecapeptide and distinguishes it from longer peptides such as TB-500.
BPC 157 5 mg vs Other British Dragon Preparations
British Dragon offers a range of research peptides and performance compounds. Within this lineup, BPC-157 is often discussed alongside TB 500, another research peptide commonly referenced for recovery purposes, though the two have distinct amino acid sequences and mechanisms.
For those exploring peptide-based recovery protocols, GHK-CU represents a different approach, focusing on copper-binding peptide activity rather than BPC-157’s angiogenic and cytoprotective pathways.
Dosage & Usage
BPC 157 5 mg Dosage & Usage
The information below is provided for educational reference only. BPC-157 is not an FDA-approved human drug. Its use for performance, recovery, or any non-medical purpose falls outside approved indications, and no established human dosing regimen exists.
Typical Dosage Ranges
Because BPC-157 lacks human pharmacokinetic data and FDA approval, there is no medically established dosage range. In non-medical bodybuilding and research communities, reference ranges are derived from animal studies and anecdotal reports, with substantial uncertainty. Commonly referenced ranges in community discussions are 250–500 mcg per day for maintenance or mild recovery support, and 500–1000 mcg per day for more aggressive recovery protocols.
| Use Case | Common Reference Range | Frequency |
|---|---|---|
| General recovery support (non-medical) | 250–500 mcg / day | Once daily |
| Active soft-tissue recovery (non-medical) | 500–1000 mcg / day | Once or twice daily |
| Combined with TB-500 (non-medical) | 250–500 mcg BPC-157 + TB-500 | Per individual protocol |
These ranges are community conventions, not evidence-based medical recommendations. No human dose-response relationship has been established, and individual response is unpredictable.
Reconstitution & Handling
BPC 157 5 mg is supplied as a lyophilized powder and requires reconstitution before use. In non-medical contexts, bacteriostatic water is commonly used as the solvent. A 5 mg vial reconstituted with 2 mL of solvent yields a concentration of 2.5 mg/mL.
Reconstituted peptide is typically stored refrigerated and used within a limited timeframe. Unreconstituted powder is more stable and should be kept under appropriate conditions.
Stacking & Cycle Considerations
In non-medical bodybuilding contexts, BPC-157 is sometimes combined with TB 500 for recovery-focused protocols. Cycle lengths commonly referenced range from 4 to 8 weeks, though no pharmacokinetic basis supports any specific cycle duration.
The healing trajectory of any underlying condition, rather than a fixed calendar, likely matters more in determining appropriate use duration. Continued use after resolution of a specific issue offers no established benefit.
Important
Individual Response Varies
No human pharmacokinetic or dose-response data exists for BPC-157. All dosage information is derived from animal research or community convention and should not be interpreted as medical guidance.
Safety & Information
Pentadecapeptide Safety Information
BPC-157 is not FDA-approved for human use. Safety data in humans is extremely limited, and non-medical use carries unknown risks.
Important Safety Information
BPC-157 has been evaluated by the FDA for inclusion on the 503A bulk drug substances list and was found not to meet the criteria for compounding. The FDA cited insufficient clinical safety information, inconsistent naming conventions, and lack of characterization data as reasons against inclusion.
There are no FDA-approved drug products containing BPC-157. Its status as a research peptide means it has not undergone the rigorous clinical trials required for human pharmaceutical approval.
Important
Non-Medical Use
BPC-157 is marketed in the United States as an ingredient in dietary supplement products, but it has not been established as safe or effective for any human indication. Non-medical use falls outside approved indications.
Potential Adverse Effects
Human safety data for BPC-157 is minimal. Adverse events reported to the FDA Adverse Event Reporting System include injection site reactions, shortness of breath, and skin pigmentation changes, though causality is unclear.
As a peptide administered parenterally, BPC-157 may pose immunogenicity risks. Aggregation and peptide-related impurities could potentially trigger immune responses.
Conditions Requiring Medical Evaluation
Given the absence of human safety data, any consideration of BPC-157 use should involve consultation with a qualified healthcare professional. Individuals with underlying health conditions, those taking medications, or those considering use during pregnancy or breastfeeding should exercise particular caution.
Monitoring During Use
No established monitoring protocol exists for BPC-157. In research contexts, any adverse reactions should be documented and reported to appropriate authorities.
Product Care
Storage & Handling
Lyophilized powder should be stored under conditions that preserve peptide stability. Protect from heat, moisture, and light. Keep out of reach of children.
Further Safety Information
Shipping & Authenticity
Shipping & Product Authenticity
BPC 157 5 mg is supplied through the official British Dragon distribution chain and shipped in original manufacturer packaging with discreet handling.
USA Domestic 3–5 business days
International 10–15 business days
Order Processing 24–48 business hours
Tracking Provided after dispatch
Direct Supply
Discreet Delivery & Original Packaging
The outer shipping package remains discreet, with privacy-focused handling. Products are supplied through the official British Dragon distribution chain.
What to Expect
- Orders are processed after payment confirmation
- USA Domestic shipping is typically faster when local stock is selected
- International orders include tracking, though update frequency may vary
- Multiple warehouses may result in separate shipments when applicable
Authenticity Verification
To verify your BPC 157 5 mg product, use the security code on the vial label and cross-check it on the British Dragon official site. Original packaging and manufacturer presentation help reinforce product legitimacy.
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Storage
BPC 157 5 mg Storage
Proper storage conditions help preserve peptide stability and integrity throughout shelf life.
Recommended Conditions
Store lyophilized powder in a cool, dry place protected from heat, moisture, and direct light. For longer-term storage, refrigeration or freezing of the unreconstituted powder may be appropriate, though specific stability data for this product is limited.
Once reconstituted, store refrigerated and use within the timeframe recommended for peptide solutions. Avoid repeated temperature fluctuations.
Keep out of reach of children. Follow proper handling practices.
Quick Reference
Do & Don't
- Do store powder protected from light and moisture
- Do keep in original packaging until use
- Do refrigerate reconstituted solution
- Don't expose to excessive heat
- Don't freeze reconstituted solution
- Don't use if solution appears cloudy or contains particles
Frequently Asked Questions
BPC 157 5 mg FAQ
Answers to common questions about BPC 157 5 mg, Pentadecapeptide, and research peptide storage.
What is BPC 157 5 mg used for?
BPC 157 5 mg is a research peptide studied in preclinical settings for its potential effects on tissue repair and recovery. In non-medical bodybuilding contexts, it is commonly referenced for tendon, ligament, and muscle recovery support, though such use falls outside approved indications and lacks rigorous clinical validation.
How often should BPC 157 5 mg be injected?
No established human dosing schedule exists. Community protocols commonly reference once or twice daily administration, but this is based on anecdotal convention rather than pharmacokinetic data.
Does BPC 157 5 mg require PCT?
BPC-157 does not suppress endogenous testosterone production and does not require post-cycle therapy in the way anabolic steroids do. However, any non-medical peptide use should be approached with caution given the absence of human safety data.
What does Pentadecapeptide do?
Pentadecapeptide refers to a peptide chain of fifteen amino acids. In the case of BPC-157, this specific sequence has been studied for effects on angiogenesis, nitric oxide signaling, and cellular protection in animal models.
How long does BPC 157 5 mg take to work?
No human data establishes a timeline for effects. Preclinical research suggests some effects may occur within days in animal models, but translation to human timelines is speculative.
Is Pentadecapeptide the best recovery peptide?
There is no universally “best” research peptide. BPC-157 is one of several peptides studied for recovery-related properties, each with distinct mechanisms. Human comparative data is essentially absent.
What is the difference between BPC 157 5 mg and TB 500?
BPC-157 and TB-500 are different peptides with different amino acid sequences and proposed mechanisms. BPC-157 is a pentadecapeptide, while TB-500 is a fragment of thymosin beta-4. Both are commonly referenced in recovery contexts but are not interchangeable.
What is the difference between BPC 157 5 mg and GHK-CU?
GHK-CU is a copper-binding tripeptide studied for skin and wound-healing applications, while BPC-157 is a larger peptide studied for broader tissue repair. They operate through different proposed pathways.
Is 500 mcg of BPC 157 a lot?
Without human dose-response data, it is impossible to characterize any amount as appropriate or excessive. Community protocols commonly reference 250–500 mcg per day, but this is convention, not evidence.
What strength is BPC 157 5 mg?
BPC 157 5 mg is labeled at 5 mg of pentadecapeptide per vial. It is supplied as a lyophilized powder in a 2 mL vial.
How should BPC 157 5 mg be stored?
Store the lyophilized powder in a cool, dry place protected from heat, moisture, and light. Once reconstituted, refrigerate and use within the recommended timeframe for peptide solutions.
Related Offers
British Dragon Pharmaceuticals
Product Information Compound Details
Active Substance TB-500 Thymosin Beta-4-Related Research Peptide
5 mgStrength 5 mg/vial
Package 1 Vial
Form Lyophilized Powder
Vial Size 2 mL Vial
Drug Class Research Peptide
Manufacturer British Dragon
British Dragon Pharmaceuticals
Product Information Compound Details
Active Substance Sermorelin Growth Hormone-Releasing Hormone (GHRH 1-29) Analog
5 mgStrength 5 mg/vial
Package 1 Vial
Form Lyophilized Powder
Vial Size 2 mL Vial
Drug Class Research Peptide
Manufacturer British Dragon
British Dragon Pharmaceuticals
Product Information Compound Details
Active Substance GHK-Cu Copper Tripeptide-1 · Gly-His-Lys Copper Complex
50 mgStrength 50 mg/vial
Package 1 Vial
Form Lyophilized Powder
Vial Size 2 mL Vial
Drug Class Research Peptide
Manufacturer British Dragon
British Dragon Pharmaceuticals
Product Information Compound Details
Active Substance MOTS-c Mitochondrial-Derived Peptide · 16 Amino Acids
10 mgStrength 10 mg/vial
Package 1 Vial
Form Lyophilized Powder
Vial Size 2 mL Vial
Drug Class Research Peptide
Manufacturer British Dragon